期刊文献+

液基薄层细胞检测系统与阴道镜下活检在诊断子宫颈病变中的价值 被引量:2

Value of Liquid-Based Thin-Layer Cell Detection System and Cervical Biopsy Vaginoscopy in Diagnosis of Cervical Lesion
暂未订购
导出
摘要 目的探讨液基薄层细胞检测系统(LCT)联合阴道镜及阴道镜下宫颈活检对宫颈上皮内瘤变(CIN)的诊断价值。方法回顾性分析7118例LCT筛查结果及其中778例细胞学阳性行阴道镜下活检的病理结果,167例虽细胞学阴性,但临床高度可疑,行阴道镜检出并取活检。结果7118例患者中,778例LCT检查提示不典型鳞状细胞以上病变者,再行阴道镜下活检发现CIN以上病变429例,检出率为6.03%(429/7118)。167例LCT检查阴性但临床高度可疑病例,行镜下活检CIN以上病变78例,总检出率为7.12%[(429+78)/7118]。两者比较差异显著(P<0.01)。结论采用LCT筛查可早期发现宫颈病变,细胞学阳性或临床可疑者应配合阴道镜检查及镜下活检可提高CIN的检出率,但如果同时进行阴道镜检查可提高CIN的检出率。 Objective To study the diagnostic value of liquid-based thin-layer cell detction system(LCT) and cervical biopsy vagionscopy for cervical intraepithelial neoplasia(CIN). Method The clinical information of 7118 patients that received LCT and 778 cases of positive cytological result that received cervical biopsy were retrospectively analyzed. 167 patients with negative result in cytological test received cervical biopsies vaginos-copy because of their high-grade clinical suspicion. Results In 7118 patients ,429 cases was diagnosed as CIN by cervical biopsy,the diagnosis rate was 6.03% (429/7118). In 167 patients,78 cases of 778 cases that were suggested as untypical squarnous cell lesions by LCT were diagnosed as CIN by cervical biopsy. The total diagnosis rate is 7.12% [ (429 ±78)/7118]. There was a significant difference between them(P 〈0.01 ). Conclusions LCT could detect cervical lesion in its early stage. The patients whose cytological test results are positive or clinical high-grade suspicious should receive cervical biopsy vaginoscopy, which may benefit to the increase of detection rate of CIN.
出处 《现代诊断与治疗》 CAS 2009年第4期199-201,共3页 Modern Diagnosis and Treatment
关键词 液基细胞学 阴道镜 宫颈上皮内瘤变 实验室诊断 Liquid-based thin-layer cell detection system Vaginoscopy Cervical intraepithelial neoplasia Labdiagnosis
  • 相关文献

参考文献1

二级参考文献9

  • 1Duke University Evaluation of cervical Cytology. Rockwille, Md. Departmem of health and Human scrvice. Pubhe health scrme agency for health care poiicc and research, 1999; AHCPR publication no.99-E010(Evidence report /technotogy assessmemt no. 5.
  • 2Cuzick F,Beverley E, Ho L,et al. HPV testing in primary screening of older women. Br J Cancer, 1999;81:554-558.
  • 3Schneider A,Zahm DM, Kirchmayr R, et al. Screening for cerical intracpithelial neopiasia grade 2/3. Am J Obstet Gynecol, 1996;174: 1534- 1541.
  • 4Rathan S,Pratull G,Frauco E,et at. Eds. Utility of HPV.testing in combination with Papanicol smear in primary cervical sereening. In Proceeding of the 17th international papillomavirus conierence;Jaanary, 1999:10-16. Charlcston, SC.
  • 5Womack SD, Chirenje ZM, Blumenthal PP, et al. eds. Evaluation of Hybrid Capturell, probe - B assay Cervicat Cancer sereening of woman in Zimbabwe,Africa. IN Proceedig of the 17th. Intemational papillomavirus conference. Janary, 1999:10- 16. Charieston,SC.
  • 6Gurlcy M,Carter CB, Bounassif S, et al. cds. Does HPV status have a role in the mangement of women with abnomal cervical Cytology? In: Proceeding of the 17th international papiiiomavirus Conferende ;Janary, 1999:10-16. Charteston, SC.
  • 7Waiboomers JM, Jacobs MV, Manos M. et al, (1999) Human paapiliomavirua is a necessats, cause of invaslve cervical cancer worldwide. J Pathol, 1999; 189:12-19.
  • 8LARC Working. Group on the evaluatton of carcinogenic rinks to Humans. Human papilkamviruses. Vol 64 of IARC monographs on the evaluation of carcinogenic Risks to Hurrahs. Lyon: International Agency for Reseach an Caneer, World Heaitrb Organizatiomn, 1995.
  • 9Schoell WM, Janicek MF, Mirhashemi R. Eidemioiogy and biology of cervical cancer. Semin Surg on, Oncol, 1999;16(3):203-211.

共引文献20

同被引文献14

  • 1Hossein R, Behzad S, Tahar M, Azadeh N A. Prevalence of human papillomavirus genotypes associated with cervical and breast cancer in iran [J]. Monoclon Antib Immunodiagn Immunother, 2013,32(6) :399 -403.
  • 2Bian M L, Cheng J Y, Ma L, et al. Evaluation of the detection of 14 high-risk human papillomaviruses with HPVI6 and HPVI8 genotyping for cervical cancer screening [J]. Exp Ther Med, 2013,6 (5):1332-6.
  • 3Ma L, Bian M L, Cheng J Y, et al, Hybrid capture II for highrisk human papillomavirus DAN testing to detect cervical precancerous lesions: a qualitative and quantitative study [J]. Exp Ther Med, 2010,1(1) :193 -8.
  • 4SolomonD,NayarR,著.子宫颈细胞学Bethesda报告系统定义、标准和注释[M]//黄受方,张长淮,余小蒙,译.北京:人民军医出版社,2009:69-75.
  • 5Arbyn M. Ronco G. Anttila A, et at. Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer [J]. Vaccine, 2012,30(5) :F88 -99.
  • 6J Wright T C r-, Massad L S, Dunton C J, et al. 2006 consensus guidelines for the management of women with ahnormal cervical cancer screening tests [J]. Am J Obstet Gynecol, 2007 , 197 ( 4 ) : 346 -55.
  • 7李虹,谢志翠,陈甦.电子阴道镜下活检诊断宫颈病变268例[J].临床和实验医学杂志,2009,8(2):104-105. 被引量:9
  • 8吴玉萍,王国平.液基细胞学和HPV原位杂交检测及其联合应用在子宫颈癌筛查中的作用[J].临床与实验病理学杂志,2010,26(4):402-406. 被引量:28
  • 9刘跃丛,宋文静.5631例宫颈病变临床病理资料分析[J].中国现代医学杂志,2011,21(1):64-68. 被引量:7
  • 10高巍,卢丹,郑萍.阴道镜下活检对诊断TCT异常者宫颈病变的临床价值[J].中国妇幼保健,2011,26(22):3501-3503. 被引量:14

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部